Ignite Creation Date:
2024-05-06 @ 3:55 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04805307
Status:
RECRUITING
Last Update Posted:
2022-12-28
First Post:
2021-03-16
Brief Title:
Safety Tolerability Pharmacokinetics and Preliminary Efficacy Phase 1 Study of CMG901
Sponsor:
Keymed Biosciences CoLtd
Organization:
Keymed Biosciences CoLtd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-16
First Submit QC Date:
March 16 2021
Study First Post Date:
2021-03-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-26
Last Update Post Date:
2022-12-28
Last Update Post Date Type:
ACTUAL